FI102515B1 - Asymmetrisiä kalvoja käsittävä väline, joka pystyy kontrolloidusti vapauttamaan aktiivista ainetta sekä menetelmiä välineiden valmistamiseksi - Google Patents

Asymmetrisiä kalvoja käsittävä väline, joka pystyy kontrolloidusti vapauttamaan aktiivista ainetta sekä menetelmiä välineiden valmistamiseksi

Info

Publication number
FI102515B1
FI102515B1 FI894046A FI894046A FI102515B1 FI 102515 B1 FI102515 B1 FI 102515B1 FI 894046 A FI894046 A FI 894046A FI 894046 A FI894046 A FI 894046A FI 102515 B1 FI102515 B1 FI 102515B1
Authority
FI
Finland
Prior art keywords
active substance
controlled release
making
devices
asymmetric membranes
Prior art date
Application number
FI894046A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI102515B (fi
FI894046A0 (fi
FI894046A (fi
Inventor
John Robert Cardinal
Scott Max Herbig
Richard Wilker Korsmeyer
Jeelin Lo
Kelly Lincoln Smith
Avinash Govind Thombre
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI894046A0 publication Critical patent/FI894046A0/fi
Publication of FI894046A publication Critical patent/FI894046A/fi
Application granted granted Critical
Publication of FI102515B publication Critical patent/FI102515B/fi
Publication of FI102515B1 publication Critical patent/FI102515B1/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Executing Machine-Instructions (AREA)
  • Materials For Medical Uses (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
FI894046A 1988-08-30 1989-08-29 Asymmetrisiä kalvoja käsittävä väline, joka pystyy kontrolloidusti vapauttamaan aktiivista ainetta sekä menetelmiä välineiden valmistamiseksi FI102515B1 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23837188A 1988-08-30 1988-08-30
US23837188 1988-08-30

Publications (4)

Publication Number Publication Date
FI894046A0 FI894046A0 (fi) 1989-08-29
FI894046A FI894046A (fi) 1990-03-01
FI102515B FI102515B (fi) 1998-12-31
FI102515B1 true FI102515B1 (fi) 1998-12-31

Family

ID=22897578

Family Applications (1)

Application Number Title Priority Date Filing Date
FI894046A FI102515B1 (fi) 1988-08-30 1989-08-29 Asymmetrisiä kalvoja käsittävä väline, joka pystyy kontrolloidusti vapauttamaan aktiivista ainetta sekä menetelmiä välineiden valmistamiseksi

Country Status (26)

Country Link
EP (1) EP0357369B1 (da)
JP (1) JPH07112971B2 (da)
KR (1) KR920008701B1 (da)
CN (2) CN1058387C (da)
AT (1) ATE89162T1 (da)
AU (1) AU615104B2 (da)
CA (1) CA1338552C (da)
CZ (1) CZ277763B6 (da)
DD (1) DD289466A5 (da)
DE (1) DE68906488T2 (da)
DK (1) DK175178B1 (da)
EG (1) EG19189A (da)
ES (1) ES2041006T3 (da)
FI (1) FI102515B1 (da)
HU (1) HU222245B1 (da)
IE (1) IE62859B1 (da)
IL (1) IL91398A (da)
MX (1) MX173942B (da)
MY (1) MY104183A (da)
NO (1) NO179232C (da)
NZ (1) NZ230470A (da)
PL (1) PL163079B1 (da)
PT (1) PT91560B (da)
RU (2) RU1837873C (da)
YU (1) YU47422B (da)
ZA (1) ZA896586B (da)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4962128A (en) * 1989-11-02 1990-10-09 Pfizer Inc. Method of treating anxiety-related disorders using sertraline
ES2067957T3 (es) * 1990-08-07 1995-04-01 Pfizer Uso de membranas polimerizadas interfacialmente en dispositivos de liberacion.
EP0550641B1 (en) * 1990-09-28 1994-05-25 Pfizer Inc. Dispensing device containing a hydrophobic medium
ZA933725B (en) * 1992-05-28 1993-12-15 Elan Corp Plc Tablet formulation
TW235239B (da) * 1992-11-20 1994-12-01 Pfizer
WO1994012159A1 (en) * 1992-11-30 1994-06-09 Pfizer Inc. Supported liquid membrane delivery devices
US5358502A (en) * 1993-02-25 1994-10-25 Pfizer Inc PH-triggered osmotic bursting delivery devices
US5798119A (en) * 1995-06-13 1998-08-25 S. C. Johnson & Son, Inc. Osmotic-delivery devices having vapor-permeable coatings
EP0811374A1 (en) * 1996-05-29 1997-12-10 Pfizer Inc. Combination dosage form comprising cetirizine and pseudoephedrine
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
KR100446366B1 (ko) * 1997-07-01 2004-09-01 화이자 인코포레이티드 서트랄린 염 및 서트랄린의 서방성 투여형
HUP0301787A3 (en) * 1997-07-01 2005-04-28 Pfizer Prod Inc Delayed-release dosage forms of sertraline
DE19814256A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Feste, schnellzerfallende Cetirizin-Formulierungen
SI1131070T1 (sl) * 1998-11-12 2008-12-31 Smithkline Beecham Plc Farmacevtski sestavek za modificirano sproĺ äśanje senzibilizatorja za inzulin in metformina
WO2000069418A1 (en) * 1999-05-17 2000-11-23 The Dow Chemical Company Process for making cellulose ether capsules with organic acids
US20030175349A1 (en) * 2001-01-30 2003-09-18 Council Of Scientific And Industrial Research Pharmaceutical compostion for extended/sustained release of a therapeutically active ingredient
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
DE60319685T2 (de) 2002-04-04 2009-03-26 Pfizer Products Inc., Groton Wohlschmeckende kautablette
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
US7611728B2 (en) * 2003-09-05 2009-11-03 Supernus Pharmaceuticals, Inc. Osmotic delivery of therapeutic compounds by solubility enhancement
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
NZ728442A (en) 2004-10-21 2018-05-25 Adare Pharmaceuticals Inc Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US20060105038A1 (en) * 2004-11-12 2006-05-18 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions prepared by coacervation
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
KR20080030637A (ko) * 2005-06-29 2008-04-04 알자 코포레이션 삼투성 제형에 대하여 감소된 건조 시간을 제공하는반투과성 조성물
AP3071A (en) 2005-11-28 2014-12-31 Marinus Pharmaceuticals Ganaxolone formulations and methods for the makingand use thereof
EP2248541B1 (de) * 2009-05-07 2018-10-31 Biotronik Ag Medikamentenbeschichteter ballonkatheter und verfahren zur herstellung desselben
CN101773484B (zh) * 2009-05-12 2013-12-25 沈阳药科大学 胃漂浮渗透泵型非匀质膜胶囊缓控释系统及其制备方法
WO2011039686A1 (en) 2009-09-30 2011-04-07 Pfizer Inc. Latrepirdine oral sustained release dosage forms
CN102958515A (zh) 2009-12-02 2013-03-06 阿普塔利斯制药有限公司 非索非那定微胶囊及含有非索非那定微胶囊的组合物
US10898865B2 (en) * 2013-01-31 2021-01-26 American University In Cairo (AUC) Polymer-carbon nanotube nanocomposite porous membranes
JP6041823B2 (ja) 2013-03-16 2016-12-14 ファイザー・インク トファシチニブの経口持続放出剤形
WO2021014360A1 (en) 2019-07-23 2021-01-28 Pfizer Inc. Oral modified release dosage forms
KR20220101150A (ko) 2019-11-14 2022-07-19 화이자 인코포레이티드 1-(((2s,3s,4s)-3-에틸-4-플루오로-5-옥소피롤리딘-2-일)메톡시)-7-메톡시이소퀴놀린-6-카복사마이드 조합물 및 경구 투여 형태
WO2021156698A1 (en) 2020-02-03 2021-08-12 Johnson & Johnson Consumer Inc. A single layer chewable tablet comprising cetirizine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL271831A (da) * 1960-11-29
DE3167521D1 (en) * 1981-01-22 1985-01-17 Capsugel Ag A process for producing a pharmaceutical capsule having enteric properties
NZ206600A (en) * 1983-05-11 1987-01-23 Alza Corp Osmotic drug delivery device
GB8322007D0 (en) * 1983-08-16 1983-09-21 Wellcome Found Pharmaceutical delivery system
US4684524A (en) * 1984-03-19 1987-08-04 Alza Corporation Rate controlled dispenser for administering beneficial agent
CA1239034A (en) * 1984-08-17 1988-07-12 Kelly L. Smith Delivery system
US4837111A (en) * 1988-03-21 1989-06-06 Alza Corporation Dosage form for dispensing drug for human therapy

Also Published As

Publication number Publication date
FI102515B (fi) 1998-12-31
CZ277763B6 (en) 1993-04-14
CN1042072A (zh) 1990-05-16
RU2093147C1 (ru) 1997-10-20
MX173942B (es) 1994-04-11
HUT74086A (en) 1996-11-28
ATE89162T1 (de) 1993-05-15
NZ230470A (en) 1991-06-25
DD289466A5 (de) 1991-05-02
NO179232C (no) 1996-09-04
KR920008701B1 (ko) 1992-10-08
IE62859B1 (en) 1995-03-08
NO893450L (no) 1990-03-01
PT91560A (pt) 1990-03-30
PT91560B (pt) 1995-05-04
DE68906488T2 (de) 1993-09-09
HU222245B1 (hu) 2003-05-28
YU47422B (sh) 1995-03-27
AU4089189A (en) 1990-05-31
CN1125573A (zh) 1996-07-03
FI894046A0 (fi) 1989-08-29
CS501189A3 (en) 1992-12-16
DK424489D0 (da) 1989-08-29
KR900002821A (ko) 1990-03-23
IE892771L (en) 1990-02-28
NO893450D0 (no) 1989-08-29
EP0357369B1 (en) 1993-05-12
EG19189A (en) 1994-11-30
AU615104B2 (en) 1991-09-19
IL91398A (en) 1994-05-30
EP0357369A3 (en) 1991-10-02
ES2041006T3 (es) 1993-11-01
DE68906488D1 (de) 1993-06-17
DK175178B1 (da) 2004-06-28
ZA896586B (en) 1991-04-24
MY104183A (en) 1994-02-28
PL163079B1 (pl) 1994-02-28
CN1058387C (zh) 2000-11-15
RU1837873C (ru) 1993-08-30
JPH02174713A (ja) 1990-07-06
JPH07112971B2 (ja) 1995-12-06
FI894046A (fi) 1990-03-01
EP0357369A2 (en) 1990-03-07
CA1338552C (en) 1996-08-27
NO179232B (no) 1996-05-28
YU165789A (en) 1992-05-28
IL91398A0 (en) 1990-04-29
DK424489A (da) 1990-03-01

Similar Documents

Publication Publication Date Title
FI102515B1 (fi) Asymmetrisiä kalvoja käsittävä väline, joka pystyy kontrolloidusti vapauttamaan aktiivista ainetta sekä menetelmiä välineiden valmistamiseksi
DE3789114D1 (de) Einen dünnen film enthaltende ultrafiltrationsmembran.
NO883837D0 (no) Anordning til avgivelse av et middel i et foerste tidsrom etterfulgt av et andre, lengre tidsrom.
ATE78422T1 (de) Zugestopfter mikroporoeser film.
NO883948D0 (no) Polyamidmembraner for revers osmose, samt fremgangsmaate for fremstilling av slike membraner.
TR27722A (tr) Kap ve onu ihtiva eden paket.
ITTO930942A1 (it) Membrane porose rivestite gas-permeabili.
FI880974A (fi) Foerfarande och foerpackning foer transport av portionspackade produkter som avger fukt och kraever avkylning.
DE3781797D1 (de) Sulfonierte bestandteile enthaltende elektrodialysemembrane.
DE68916457D1 (de) Einrichtung zur Molekularstrahlepitaxie.
ES2018492B3 (es) Dispositivo automatico para la difusion de gases desinfectantes.
DE3883921D1 (de) Vorrichtung mit Membrane.
DE68906339D1 (de) Unter hochdruck arbeitende nassbehandlungsvorrichtung.
DE3887225D1 (de) Beregnungsvorrichtung.
DE3781908D1 (de) Folientransportvorrichtung.
ATE101538T1 (de) Einen duennen film enthaltende ultrafiltrationsmembran.
NL184863C (nl) Beregeningsinrichting.
ATE96307T1 (de) Loeslichkeit-modulierte arzneimittelvorrichtung.
NO900780D0 (no) Fotokromisk polymerisk membran.
GR870214B (en) Device for splitting fluid and stable compounds,new type washer witha larger diameter placed at the accelerating membrane

Legal Events

Date Code Title Description
FG Patent granted

Owner name: PFIZER INC.

MA Patent expired